Executives
-
Guindo ChirfiChief Marketing Officer -
Smart DaltonSVP Fin. - Global Controller
-
Deluca Richard R.EVP&Pres, Merck Animal Heallth
-
Oosthuizen Johannes JacobusPresident, U.S. Market
-
Larson Betty DEVP, Chief HR Officer
-
Downing Cristal NChief Comm. & Public Afrs Ofcr
-
Zachary JenniferEVP, General Counsel
-
Li Dean YExecutive VP & President, MRL
-
Davis Robert MChairman, CEO & President
-
Chattopadhyay SanatExe V-P & Pres. MMD
-
Williams David MichaelEVP,Chief Info&Digital Officer
-
Litchfield CarolineEVP & CFO
-
Mizell StevenEVP, Chief HR Officer
?
Deluca Richard R.
EVP&Pres, Merck Animal Heallth
Merck & Co., Inc.
US, Kenilworth [HQ]
CIK
1421339
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
163,719,559
Price per Share :
$100.70
Equivalence :
$16,486,559,591.30
Transaction History
-
M163,719,559 Shares After TransactionValue : $20,875,880,968.09$3,458,836.26Transaction Date : 05/04/24
-
Footnotes
-
-
Footnotes:#1 Holdings include shares acquired in dividend reinvestment transactions.
-
F150,359,559 Shares After TransactionValue : $19,172,347,368.09$1,703,533.60Transaction Date : 05/04/24
-
Footnotes
-
-
Footnotes:#1 Holdings include shares acquired in dividend reinvestment transactions.
-
A135,782,983 Shares After TransactionValue : $16,216,561,659.69$2,782,241.28Transaction Date : 01/22/24
-
Footnotes
-
-
Footnotes:#1 Distribution of net after tax shares of common stock on satisfaction of performance criteria for performance share units granted on 3/31/21. Performance shares were paid out at 161 percent of target awards. Includes dividends accrued over the three-year performance period ending December 31, 2023.#2 Holdings include shares acquired in dividend reinvestment transactions.